Engineering of immunoinstructive extracellular matrices for enhanced osteoinductivity

Area of Science:

• Biomaterials Science
• Immunology
• Regenerative Medicine
• Tissue Engineering

Background:

• The immune system plays a critical role in initiating and guiding tissue regeneration.
• Extracellular matrices (ECMs) can be engineered as implantable materials to deliver specific biological signals.
• Optimizing ECMs for bone regeneration requires enhancing their immunomodulatory properties.

Purpose of the Study:

• To enhance the osteoinductive capacity of engineered ECMs by incorporating immunomodulatory factors.
• To investigate the impact of inflammatory priming on ECM composition and function in bone regeneration.
• To develop off-the-shelf biomaterials that promote faster and more efficient bone formation.

Main Methods:

• Engineering cell-derived ECMs using a cell line overexpressing Bone Morphogenetic Protein-2 (BMP-2).
• Priming the cell line with Interleukin-1 beta (IL1β) to modulate ECM composition.
• Characterizing ECMs for osteoinductive, angiogenic, and pro-inflammatory molecule content (e.g., VEGF, IL6, IL8, MCP1).
• Implanting the engineered ECMs in a bone regeneration model and evaluating inflammatory and regenerative responses.

Main Results:

• IL1β priming resulted in ECMs with preserved osteoinductive signals and increased levels of angiogenic and pro-inflammatory factors.
• Implanted IL1β-induced ECMs promoted early inflammatory phase events, including vascular invasion and osteoclast activity.
• These materials facilitated 'regenerative' events such as M2 macrophage polarization.
• Accelerated and enhanced bone formation was observed in the presence of the engineered ECMs.

Conclusions:

• Engineering ECMs with specific immunomodulatory factors, like those induced by IL1β priming, can significantly enhance bone regeneration.
• This strategy leads to the development of potent, off-the-shelf osteoinductive materials.
• The findings support a broader paradigm of designing 'immunoinstructive' implants to optimize tissue regeneration outcomes.